FindTrial
Sign In

Clinical Efficacy Evaluation of Lifestyle Prevention of Traditional Chinese Medicine (TCM) and the Study of TCM Pathogenesis in Pre-Diabetes

Clinical Efficacy Evaluation of Lifestyle Prevention of Traditional Chinese Medicine (TCM) and the Study of TCM Pathogenesis in Pre-Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016549
Enrollment
Unknown
Registered
2018-06-07
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pre-Diabetes

Interventions

Case series:Traditional Chinese Medicine (TCM) comprehensive scheme of prevention and treatment

Sponsors

Shanghai Shuguang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 40-70 years; 2. Meeting the standard of abnormal glucose tolerance: fasting venous plasma glucose < 7.0mmol/L, 7.8mmol/L = 2h plasma glucose after 75g OGTT < 11.1mmol/L; 3. Fasting venous plasma glucose = 5.6mmol/L; 4. Willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Women in pregnancy or lactation; 2. Body Mass Index (BMI) < 18.5kg/m2; 3. Serious heart, liver, kidney and other complications, or combined with other serious primary diseases, mental patients; 4. Abnormal blood glucose by other causes; 5. Allergy to related drugs during treatment.

Design outcomes

Primary

MeasureTime frame
Annual incidence of T2DM;—

Secondary

MeasureTime frame
Annual recurrent rate of glucose tolerance;Incidence of adverse events/serious adverse events;—

Countries

China

Contacts

Public ContactLu Hao

Shanghai Shuguang Hospital

luhaodetcm@163.com+86 18724061306

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026